CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Pregnancy outcomes in women with epilepsy using lamotrigine.
Maria Lee, Ka Hyun Nam, Ja Young Kwon, Yong Won Park, Young Han Kim
Obstet Gynecol Sci. 2009;52(12):1245-1251.   Published online December 1, 2009

Excel Download

Preliminary Results on Pregnancy Outcomes in Women Using Lamotrigine
Epilepsia. 2002;43(10):1161-1167   Crossref logo
Link1 Link2

Lamotrigine and Pregnancy
Controversies in Caring for Women with Epilepsy. 2016;125-132   Crossref logo

Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period
Epilepsy Research. 2009;85(1):60-64   Crossref logo
Link1 Link2

Management of pregnant women with epilepsy who use lamotrigine
Epilepsy Research. 2018;140:198   Crossref logo
Link1 Link2

Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy
Epilepsia. 2008;49(6):1075-1080   Crossref logo
Link1 Link2

Pregnancy outcomes in women with epilepsy: A systematic review and meta-analysis of published pregnancy registries and cohorts
Epilepsy Research. 2008;81(1):1-13   Crossref logo
Link1 Link2

Pregnancy Effects on Lamotrigine Levels
Epilepsy Currents. 2002;2(6):183-183   Crossref logo
Link1 Link2 Link3

Affect of Seizures during Gestation on Pregnancy Outcomes in Women with Epilepsy
Epilepsy Currents. 2010;10(2):40-41   Crossref logo
Link1 Link2 Link3

Individual changes in lamotrigine plasma concentrations during pregnancy
Epilepsy Research. 2005;65(3):185-188   Crossref logo
Link1 Link2

Lamotrigine for refractory epilepsy - too costly?
PharmacoEconomics & Outcomes News. 1998;157(1):10-10   Crossref logo
Link1 Link2 Link3